ADHERENCE: A REAL WORLD RETROSPECTIVE DATABASE STUDY AMONG TYPE 2 DIABETES PATIENTS TREATED WITH LIRAGLUTIDE OR EXENATIDE

被引：0
|
作者：
Maria, M. [1 ]
Carlqvist, P. [2 ]
Langer, J. [3 ]
Bouchard, J. [3 ]
机构：
[1] Evidence Dev Ltd, Stockholm, Sockholm, Sweden
[2] Heron AB, Stockholm, Sweden
[3] Novo Nordisk Inc, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1695
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A503 / A503
页数：1
相关论文
共 50 条
  • [31] Investigational treatments for Type 2 diabetes mellitus:: exenatide and liraglutide
    Gonzalez, Claudio
    Beruto, Valeria
    Keller, Guillermo
    Santoro, Silvina
    Di Girolamo, Guillermo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (08) : 887 - 895
  • [32] Risk of cardiovascular events in patients with type 2 diabetes treated with exenatide or other glucose lowering therapies: a retrospective analysis of the LifeLink® database
    Best, J. H.
    Hoogwerf, B. J.
    Pelletier, E. M.
    Smith, D. B.
    Wenten, M.
    Hussein, M. A.
    DIABETOLOGIA, 2010, 53
  • [33] A NETWORK META ANALYSIS TO COMPARE GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH EXENATIDE ONCE WEEKLY OR LIRAGLUTIDE
    Scott, D.
    Boye, K. S.
    Timlin, L.
    Best, J. H.
    Clark, J.
    VALUE IN HEALTH, 2011, 14 (07) : A472 - A473
  • [34] Real-World Outcomes of Initiating Injectable Therapy With Insulin Glargine or Liraglutide Among Patients With Type 2 Diabetes
    Levin, Philip
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Lin, Jay
    Baser, Onur
    DIABETES, 2012, 61 : A4 - A4
  • [35] Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort
    Mirani, Marco
    Favacchio, Giuseppe
    Serone, Eliseo
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    Berra, Cesare C.
    PHARMACOLOGICAL RESEARCH, 2018, 137 : 270 - 279
  • [36] GLYCEMIC OUTCOMES AMONG PATIENTS RECEIVING EXENATIDE BID OR LIRAGLUTIDE FOR TYPE 2 DIABETES IN CLINICAL PRACTICE: A RETROSPECTIVE ANALYSIS OF THE GE CENTRICITY EMR DATA
    Best, J. H.
    Wintle, M.
    Saunders, W. B.
    DeYoung, M. B.
    Blickensderfer, A.
    Maggs, D.
    VALUE IN HEALTH, 2011, 14 (07) : A473 - A473
  • [37] RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES TREATED WITH EXENATIDE OR THIAZOLIDINEDIONES: A RETROSPECTIVE ANALYSIS OF THE PHARMETRICS DATABASE
    Best, J. H.
    Pelletier, E.
    Hoogwerf, B. J.
    Herman, W. H.
    DeYoung, M. B.
    Smith, D. B.
    Yushmanova, I
    Hussein, M.
    VALUE IN HEALTH, 2010, 13 (03) : A56 - A56
  • [38] Real-World Adherence and Effectiveness of Remote Patient Monitoring Among Medicaid Patients With Diabetes: Retrospective Cohort Study
    Park, Sulki
    Kum, Hye-Chung
    Zheng, Qi
    Lawley, Mark A.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [39] Blood Pressure Outcomes after 6 Months of Exenatide Treatment in Patients with Type 2 Diabetes in a Real World Study
    Fabunmi, Rosalind
    Mcadam-Marx, Carrie
    Ye, Xiangyang
    Misurski, Derek
    Brixner, Diana I.
    DIABETES, 2009, 58 : A125 - A125
  • [40] Adherence as a Predictor of Glycemic Control Among Adolescents With Type 1 Diabetes: A Retrospective Study Using Real-world Evidence
    Ibrahim, Sohayla A.
    El Hajj, Maguy Saffouh
    Owusu, Yaw B.
    Al-Khaja, Maryam
    Khalifa, Amel
    Ahmed, Dalia
    Awaisu, Ahmed
    CLINICAL THERAPEUTICS, 2022, 44 (10) : 1380 - 1392
12345